Financials in USD. Standardized financial statements.
A compact view of how Arcadia Biosciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.86M | $5.04M | $4.45M | $7.42M | $6.78M | $8.03M | $1.17M | $1.46M | $4.03M | $3.19M |
| Revenue Growth? | -3.7% | +13.3% | -40.0% | +9.4% | -15.6% | +587.3% | -20.2% | -63.6% | +26.3% | 0.0% |
| Cost of Revenue? | $3.10M | $2.96M | $2.17M | $6.10M | $8.71M | $5.20M | $885,000 | $661,000 | $283,000 | $895,000 |
| Gross Profit? | $1.76M | $2.08M | $2.28M | $1.32M | -$1.93M | $2.83M | $284,000 | $803,000 | $3.74M | $2.29M |
| Gross Margin? | +36.2% | +41.3% | +51.2% | +17.8% | -28.4% | +35.3% | +24.3% | +54.8% | +93.0% | +71.9% |
| Operating Expenses? | $11.76M | $5.73M | $8.38M | $15.32M | $33.60M | $15.61M | $19.66M | $17.67M | $18.06M | $20.91M |
| Operating Income? | -$9.99M | -$3.65M | -$6.10M | -$14.01M | -$35.53M | -$12.78M | -$19.38M | -$16.87M | -$14.31M | -$18.62M |
| EBITDA? | -$9.96M | -$7.50M | -$5.73M | -$14.75M | -$27.71M | -$5.44M | -$28.67M | -$13.32M | -$14.65M | -$17.98M |
| Income Before Tax | -$2.33M | -$4.31M | -$5.32M | -$10.81M | -$16.13M | -$6.15M | -$28.87M | -$13.47M | -$15.68M | -$19.60M |
| Income Tax Expense | $8,000 | $8,000 | $8,000 | $14,000 | $2,000 | -$124,000 | $2,000 | $10,000 | $26,000 | $25,000 |
| Net Income? | -$2.34M | -$7.04M | -$13.98M | -$15.38M | -$14.66M | -$4.66M | -$28.80M | -$13.48M | -$15.71M | -$19.62M |
| EPS? | $-1.71 | $-5.16 | $-11.30 | $-26.05 | $-30.33 | $-24.20 | $-181.50 | $-143.16 | $-291.38 | $-353.85 |
| Diluted EPS? | $-1.71 | $-5.16 | $-11.30 | $-26.05 | $-30.33 | $-24.20 | $-181.50 | $-143.16 | $-291.38 | $-353.85 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality